John Beadle

John Beadle has extensive work experience in the biotechnology and pharmaceutical industry. John currently serves as the Chairman of Stroma Biosciences and InnDura Therapeutics. John is also a Non-Executive Director at PNEUMAGEN LIMITED. Previously, they were the Founder and Non-Executive Director of PsiOxus Therapeutics Ltd, where they also held the position of Founding Chief Executive Officer.

Prior to that, John Beadle was the CEO of Myotec and Hybrid Biosystems Limited, where they successfully raised financing, revised business strategies, and executed key partnerships. John also served as the Entrepreneur in Residence at TOUCHSTONE INNOVATIONS INVESTMENT MANAGEMENT LIMITED, where they provided advice and interim CEO management for various start-ups.

John Beadle has held leadership positions at Pfizer, PowderMed, and PowderJect Vaccines, where they played key roles in product development and successful trade-sale exits. Throughout their career, they have demonstrated a strong track record of driving innovation, securing funding, and leading strategic initiatives in the biotech and pharmaceutical industry.

John Beadle completed their primary education at St. Martins from 1978 to 1984. John then pursued a degree in Medicine at the University of the Witwatersrand from 1984 to 1990, achieving an MBBCh qualification. Following this, John attended the South African College of Medicine, specializing in Anaesthesia and earning a DA degree in 1994. Later, they enrolled at the London Business School, where they completed an MBA program from 1997 to 1999.